glp-1 bone density loss Effects of Glucagon-Like Peptide-1 receptor agonists on health in people living with obesity | Osteoporosis International Bone loss with GLP-1? Comment:

Talk to Your Provider About Dosing If side effects feel too strong, a provider may: keep you at a lower dose longer delay the next dose increase in some cases, reduce the dose Never change your dose on your own

While these symptoms typically improve over time, they can be challenging for some patients to tolerate, particularly during the initial stages of treatment

Prescription weight-management medications may be used (in combination with a reduced-calorie diet and increased physical activity) for people with one of the following conditions: A body mass index (BMI) of 30 or higher A BMI of 27 or higher with a weight-related condition such as high blood pressure or type 2 diabetes GLP-1 and weight-management medications may also be prescribed for reasons outside of this list

She now takes additional medications for excessive vomiting